Capstan Medical Submits IPO Prospectus: Pioneering Robotic Platform for Transcatheter Mitral and Tricuspid Valve Replacement

May 11, 2024 00:02 CST Updated 00:02

Capstan Medical

Minimally Invasive Technology Developer

Source: MedRobot; Editor: Sophia

Reprint Requirements: Please indicate the source of the article at the beginning of the text, and it can be reprinted directly.

In-Depth Disassembly Closed-Door Session of Endoscopic Surgical Robots

Global Surgical Robotics Conference 2024: Forum, Exhibition, Awards

Doctor Community: Papers, Surgical Videos, Surgical Robot Trials

MedRobot

May 8, 2024Surgical Robotics Company Capstan MedicalalCEO Maggie Nixon stated that the company is advancing the first human mitral valve heart valve replacement surgery.

Maggie Nixon stated that she hopes her subsidiaryTranscatheter Valve Surgery RobotThe platform can2026Start pivotal trials and in2028Obtained FDA approval.

At the same time, the company willFor tricuspid and aortic surgeryDevelop new products.

# Research and Development Background

Huge demand

Heart disease isOne of the top 10 leading causes of death among American patients, claiming nearly7 millionAmerican lives.

Image data sourced from the U.S. Centers for Disease Control and Prevention (CDC)

For more detailed information, see the URL: https://www.cdc.gov/nchs/data/databriefs/db492-tables.pdf#4

According to incomplete data statistics, a total of 175,300 heart valve replacements were performed in the United States in 2018, including 99,800 surgical bioprosthetic valves and 60,300 interventional bioprosthetic valves.

Valvular heart disease falls under structural heart disease, with clinical manifestations of morphological and structural abnormalities in one or more valves.

If the valve becomes abnormal, such as stenosis or insufficiency, it will impede normal blood flow and subsequently cause functional damage to the heart. The 5-year survival rate for patients with moderate to severe valvular disease who do not receive treatment is only 20%.

Industry Pain Points

Traditional heart valve surgery remains highly invasive and has a longer recovery time.And currently, there are no FDA-approved transcatheter mitral or tricuspid valve replacement options available, so heart valve replacement largely still relies on manual procedures.

# Core Technology

Capstan Medical is developingNew Generation Heart Valve ImplantsAndThe world's first transcatheter robotic delivery platform，A solution capable of treating mitral and tricuspid valve diseases through catheterization during heartbeats.

Capstan Medical Cardiac Robotic Surgery System

Working Principle:

Through minimally invasive methodsInsert the catheter into the patient's heart；

ThenOperating Robotic Delivery Platform, accurately positioning the heart valve implant to the location of the original valve that needs replacement or repair;

Can monitor and adjust the position and angle of the catheter in real time to adapt to different anatomical structures, lesion types, and pathological conditions;

Capstan Medical's Mitral Valve Implant

Next, the doctor releases the heart valve implant through the robotic delivery platform, allowing it to expand and secure itself in the position of the original valve.

System Advantages:

Open-heart surgery refers to surgical procedures performed by opening the chest cavity to gain visual access and operate on the heart muscle, valves, or arteries.It takes 3-6 hours, and the patient's chest will be opened 8 to 10 inches.

Thoracotomy is typicallyTriggering a variety of complications,Such as respiratory system complications, anemia, nervous system complications, wound and respiratory tract infections, impact on upper limb activity, and concurrent incisional hernia, etc.

Capstan Medical's Delivery Catheter and Mitral Valve Implant

Capstan MedicalFor patientsProvide a less invasive alternative, while ensuring the precise placement of heart valve implants, significantly shortening patient recovery time, and minimizing the risk of complications.

Transcatheter treatment can address heart valve disease through a small incision in the groin, whileWithoutAccording to open-heart surgeryRequire stopping the heartbeat or opening the chest。

This technology can reduce the patient's recovery time from several months to just a few weeks, and even the most critically ill patients can undergo such surgery.

# Financing and Team

On August 9, 2023, Capstan Medical announced the completion$31.4 Million Series B FinancingLed by Eclipse,Intuitive VenturesAnd Puma Venture Capital followed up with an investment.

Also announced the appointment of Eclipse partner Justin Butler as a member of its board of directors.

Dan Wallace (left) and Maggie Nixon (right)

The confidence in Capstan Medical stems from the resumes and experience of its two founders.

Dan Wallace，Founder and Chief Technology Officer,With experience at renowned surgical robotics and valve companies such as Intuitive Surgical, Hansen Medical, Auris Health (acquired by Johnson & Johnson), and Cephea Valve Technologies (acquired by Abbott).

Maggie Nixon，Founder and CEO,With over 20 years of experience working at Intuitive Surgical.

# About Capstan Medical

Capstan Medical was founded in 2020, originating from Occam Labs. Founders Dan Wallace and David Schummers have over 50 years of collective experience in startups and commercial medical technology.

They, along with founding engineers Spencer Noe and Peter Gregg, formed a team,Simultaneously developing implants, catheters, and surgical robot platforms,Bringing Minimally Invasive Solutions to Cardiac Salvage Surgery.

The main members of the team, besidesDan Wallace、In addition to Maggie Nixon, it also includes:

Currently, the company has not disclosed more information and details about the product, and MedRobot will continue to follow up.

Well-known Surgical Robotics Companies in China:

Minimally Invasive Robot | Capstan Medical | Rosunbot | Aibo Medical Robotics |

Yuanhua Intelligence | Capstan Medical | Capstan Medical | Capstan Medical |

Capstan Medical | Capstan Medical | Capstan Medical | Zhiyu Medical | True Health

Updates from Other Surgical Robotics Companies:

Progress of Chinese Surgical Robotics Companies | Progress of Overseas Surgical Robotics Companies

Intelligent Surgery Innovation Enterprise:

NDI ｜ UR ｜Capstan Medical｜With Capstan Medical

Surgical Robotics Industry 2023:

2023 Surgical Robotics Industry Awards

The First Global Surgical Robotics Conference

2023 China Surgical Robot Product Approval Overview

2023 Review of Financing in China's Medical Robotics Companies

2023 China Innovative Medical Devices for Surgical RobotsInventory